Windtree Therapeutics Inc (WINT)
3.50
-0.07
(-1.98%)
USD |
NASDAQ |
Jun 03, 16:00
3.57
+0.07
(+2.00%)
After-Hours: 20:00
Windtree Therapeutics Enterprise Value: -0.4335M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -0.4335M |
| May 30, 2024 | -0.3925M |
| May 29, 2024 | -0.3925M |
| May 28, 2024 | -0.3054M |
| May 24, 2024 | -0.2386M |
| May 23, 2024 | -0.4043M |
| May 22, 2024 | -0.1173M |
| May 21, 2024 | -0.0314M |
| May 20, 2024 | 0.0396M |
| May 17, 2024 | 0.1106M |
| May 16, 2024 | -0.0018M |
| May 15, 2024 | 0.1765M |
| May 14, 2024 | -0.4756M |
| May 13, 2024 | -0.5419M |
| May 10, 2024 | -0.4551M |
| May 09, 2024 | -0.3327M |
| May 08, 2024 | -0.1133M |
| May 07, 2024 | -0.3021M |
| May 06, 2024 | -0.0598M |
| May 03, 2024 | -0.0266M |
| May 02, 2024 | -0.3378M |
| May 01, 2024 | -0.2562M |
| April 30, 2024 | 0.0372M |
| April 29, 2024 | 0.1571M |
| April 26, 2024 | 0.1213M |
| Date | Value |
|---|---|
| April 25, 2024 | 0.0398M |
| April 24, 2024 | 0.0831M |
| April 23, 2024 | 0.3526M |
| April 22, 2024 | 0.2336M |
| April 19, 2024 | 0.592M |
| April 18, 2024 | 0.5736M |
| April 17, 2024 | 1.138M |
| April 16, 2024 | 1.324M |
| April 15, 2024 | 1.350M |
| April 12, 2024 | 1.448M |
| April 11, 2024 | 0.9336M |
| April 10, 2024 | 0.9428M |
| April 09, 2024 | 0.8601M |
| April 08, 2024 | 1.218M |
| April 05, 2024 | 1.344M |
| April 04, 2024 | 0.9758M |
| April 03, 2024 | 0.9428M |
| April 02, 2024 | 0.8326M |
| April 01, 2024 | 0.8142M |
| March 28, 2024 | -0.8356M |
| March 27, 2024 | -0.708M |
| March 26, 2024 | -0.8384M |
| March 25, 2024 | -0.7815M |
| March 22, 2024 | -0.7806M |
| March 21, 2024 | -0.8265M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.288M
Minimum
Sep 25 2023
167.50M
Maximum
Dec 06 2019
44.46M
Average
18.30M
Median
Dec 03 2021
Enterprise Value Benchmarks
| Lexicon Pharmaceuticals Inc | 358.84M |
| AIM ImmunoTech Inc | 10.88M |
| Perspective Therapeutics Inc | 680.29M |
| Protalix BioTherapeutics Inc | 54.78M |
| Armata Pharmaceuticals Inc | 192.52M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 10.22M |
| Total Expenses (Quarterly) | 4.405M |
| EPS Diluted (Quarterly) | 21.98 |
| Earnings Yield | -1.04K% |
| Normalized Earnings Yield | -168157.5 |